Both in Pharmaceuticals
Aquestive Therapeutics vs Evolus
Over the past year AQST returned −40.2% and EOLS returned +15.3%; their daily moves had a correlation of 0.17.
AQST −40.2% EOLS +15.3%Growth of $1, one year, split-adjusted
| Metric | AQST | EOLS |
|---|---|---|
| Price | $3.88 | $7.37 |
| Market cap | $487.0M | $486.8M |
| Today | +2.92% | +2.93% |
| 1 month | −15.1% | −1.3% |
| 6 months | −7.2% | +15.7% |
| Year to date | −39.9% | +10.8% |
| 1 year | −43.1% | +14.1% |
| Revenue growth (YoY) | +38.1% | +21.2% |
| Gross margin | 70.9% | 68.0% |
| Net margin | −165.5% | −9.6% |
| P/E (TTM) | — | — |
| Price / sales | 9.0× | 1.5× |
| Net cash | $47.8M | -$141.9M |
| Dividend yield | — | — |
| Volatility (60d) | 54.4% | 52.8% |
| Short % of float | 25.6% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).